Uncertainty in the Generic Versus Brand Name Prescription Decision
نویسندگان
چکیده
This paper analyzes the impact of uncertainty concerning product quality of generic drugs on the substitution behavior of prescribing physicians. It is shown that uncertainty about the generic drug quality gives the physician a value of waiting for more information before switching to the generic version. In addition, it is shown that reducing the approval requirements for generic drugs, thereby increasing uncertainty about quality, may discourage physicians from prescribing such drugs. A small empirical study supports the theoretical findings and indicate that uncertainty about the quality of generic drugs do affect physician prescription behavior. (JEL L65, I11) ∗Financial support from the Jan Wallander and Tom Hedelius foundation is greatly acknowledged.
منابع مشابه
Prescription for fairness: a new approach to tort liability of brand-name and generic drug manufacturers.
Over the past two decades, courts have consistently ruled that the manufacturer of a brand-name prescription drug cannot be liable for injuries suffered by those taking generic imitations of its product. This meant that a patient injured by a generic drug could have no remedy at all because in many instances the generic drug manufacturer would escape liability on the ground that it did not prod...
متن کاملBrand Name and Generic Proton Pump Inhibitor Prescriptions in the United States: Insights from the National Ambulatory Medical Care Survey (2006–2010)
Introduction. Proton pump inhibitors (PPI) are one of the most commonly prescribed medication classes with similar efficacy between brand name and generic PPI formulations. Aims. We determined demographic, clinical, and practice characteristics associated with brand name PPI prescriptions at ambulatory care visits in the United States. Methods. Observational cross sectional analysis using the N...
متن کاملFactors influencing consumer purchasing patterns of generic versus brand name over-the-counter drugs.
OBJECTIVES US consumers spend more than $20 billion/year on over-the-counter (OTC) drugs. Although generic and brand name OTC drugs share the same active ingredients and undergo the same rigorous Food and Drug Administration approval process, brand name formulations continue to lead the OTC drug market with a higher market share. There is a limited amount of publicly available information regar...
متن کاملPrescription Drug Benefits: Cost Management Issues for Medicare
Little attention has been devoted in policy circles as to how Medicare would manage an outpatient prescription drug benefit. This article, first, discusses the role of the pharmacy benefits manager (PBM), the entity that processes claims and otherwise helps administer the benefit. It then discusses the major decisions that will be necessary regarding such matters as: which drugs should be cover...
متن کاملComparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study.
BACKGROUND Statins are effective in preventing cardiovascular events, but patients do not fully adhere to them. OBJECTIVE To determine whether patients are more adherent to generic statins versus brand-name statins (lovastatin, pravastatin, or simvastatin) and whether greater adherence improves health outcomes. DESIGN Observational, propensity score-matched, new-user cohort study. SETTING...
متن کامل